全文获取类型
收费全文 | 37347篇 |
免费 | 4093篇 |
国内免费 | 2554篇 |
专业分类
耳鼻咽喉 | 382篇 |
儿科学 | 625篇 |
妇产科学 | 149篇 |
基础医学 | 2207篇 |
口腔科学 | 622篇 |
临床医学 | 4515篇 |
内科学 | 2764篇 |
皮肤病学 | 345篇 |
神经病学 | 879篇 |
特种医学 | 1518篇 |
外科学 | 3386篇 |
综合类 | 10556篇 |
现状与发展 | 9篇 |
预防医学 | 4456篇 |
眼科学 | 548篇 |
药学 | 4944篇 |
61篇 | |
中国医学 | 4386篇 |
肿瘤学 | 1642篇 |
出版年
2025年 | 6篇 |
2024年 | 645篇 |
2023年 | 650篇 |
2022年 | 1357篇 |
2021年 | 1711篇 |
2020年 | 1471篇 |
2019年 | 741篇 |
2018年 | 756篇 |
2017年 | 1093篇 |
2016年 | 831篇 |
2015年 | 1454篇 |
2014年 | 1944篇 |
2013年 | 2434篇 |
2012年 | 3362篇 |
2011年 | 3632篇 |
2010年 | 3420篇 |
2009年 | 2921篇 |
2008年 | 2994篇 |
2007年 | 2845篇 |
2006年 | 2528篇 |
2005年 | 2019篇 |
2004年 | 1389篇 |
2003年 | 1080篇 |
2002年 | 814篇 |
2001年 | 794篇 |
2000年 | 589篇 |
1999年 | 233篇 |
1998年 | 35篇 |
1997年 | 28篇 |
1996年 | 37篇 |
1995年 | 26篇 |
1994年 | 29篇 |
1993年 | 19篇 |
1992年 | 13篇 |
1991年 | 10篇 |
1990年 | 4篇 |
1989年 | 7篇 |
1988年 | 3篇 |
1987年 | 8篇 |
1986年 | 13篇 |
1985年 | 3篇 |
1982年 | 6篇 |
1965年 | 3篇 |
1964年 | 3篇 |
1962年 | 3篇 |
1959年 | 6篇 |
1958年 | 7篇 |
1957年 | 4篇 |
1956年 | 3篇 |
1954年 | 2篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
101.
102.
Jie LIU Xin-Xing FENG Yan-Feng DUAN Jun-Hao LIU Ce ZHANG Lin JIANG Lian-Jun XU Jian TIAN Xue-Yan ZHAO Yin ZHANG Kai SUN Bo XU Wei ZHAO Ru-Tai HUI Run-Lin GAO Ji-Zheng WANG Jin-Qing YUAN Xin HUANG Lei SONG 《老年心脏病学杂志》2022,19(5):367
BACKGROUNDThree-vessel disease (TVD) with a SYNergy between PCI with TAXus and cardiac surgery (SYNTAX) score of ≥ 23 is one of the most severe types of coronary artery disease. We aimed to take advantage of machine learning to help in decision-making and prognostic evaluation in such patients.METHODSWe analyzed 3786 patients who had TVD with a SYNTAX score of ≥ 23, had no history of previous revascularization, and underwent either coronary artery bypass grafting (CABG) or percutaneous coronary intervention (PCI) after enrollment. The patients were randomly assigned to a training group and testing group. The C4.5 decision tree algorithm was applied in the training group, and all-cause death after a median follow-up of 6.6 years was regarded as the class label.RESULTSThe decision tree algorithm selected age and left ventricular end-diastolic diameter (LVEDD) as splitting features and divided the patients into three subgroups: subgroup 1 (age of ≤ 67 years and LVEDD of ≤ 53 mm), subgroup 2 (age of ≤ 67 years and LVEDD of > 53 mm), and subgroup 3 (age of > 67 years). PCI conferred a patient survival benefit over CABG in subgroup 2. There was no significant difference in the risk of all-cause death between PCI and CABG in subgroup 1 and subgroup 3 in both the training data and testing data. Among the total study population, the multivariable analysis revealed significant differences in the risk of all-cause death among patients in three subgroups.CONCLUSIONSThe combination of age and LVEDD identified by machine learning can contribute to decision-making and risk assessment of death in patients with severe TVD. The present results suggest that PCI is a better choice for young patients with severe TVD characterized by left ventricular dilation.Coronary artery disease (CAD) is the leading cause of death and disability worldwide.[1] Three-vessel disease (TVD) is the most severe form of CAD and is characterized by significant stenosis in all three major coronary arteries. The application of myocardial revascularization techniques, including coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI), has significantly improved the clinical outcomes of patients with severe CAD. CABG has traditionally been the standard therapy for complex coronary lesions, including TVD.[2] In recent years, with the advancements in PCI technology and the accumulation of operators’ experience, the incidence of periprocedural and long-term adverse events of PCI has substantially decreased, and PCI has been gradually applied in the treatment of TVD.[3,4] Current guidelines recommend use of the SYNergy between PCI with TAXus and cardiac surgery (SYNTAX) score and diabetes status to guide the revascularization strategy for patients with TVD.[5,6] Current practice guidelines do not recommend PCI for patients with TVD with a SYNTAX score of ≥ 23. However, using the SYNTAX score to guide clinical decision-making between PCI and CABG remains controversial, and its reasonability has been questioned since a newly published meta-analysis showed no significant association between the SYNTAX score and the comparative effectiveness of PCI and CABG.[7] Moreover, the SYNTAX score is a quantitative indicator of the anatomical complexity of TVD and does not include clinical variables that may have significant effects on the patient’s prognosis. Whether some patients with specific clinical characteristics can obtain a comparable or even greater survival benefit from PCI than from CABG is unclear. Moreover, risk assessment for patients with TVD after revascularization therapy remain challenging.[8–10]Machine learning has recently emerged as an important research method and has been successfully applied in many scientific fields, including clinical medicine.[11–13] The decision tree algorithm, a common approach in machine learning, can handle non-linearity, heterogeneous effects, and high-dimensional features and partition a trial population into subgroups characterized by multiple simultaneous characteristics.[14] In the present study involving a large cohort of patients with TVD with a SYNTAX score of ≥ 23, we employed a decision tree algorithm to generate specific subgroups, compared the long-term prognosis between patients who underwent PCI or CABG in each subgroup, and conducted a comparative analysis of the long-term prognosis between subgroups generated by machine learning. We evaluated whether machine learning can help in selecting the optimal revascularization method and assessing risk in patients with severe TVD. 相似文献
103.
目的了解安徽省志贺氏菌的流行菌型,并建立脉冲场凝胶电泳(PFGE)分子分型方法,为菌痢防控提供理论基础。方法对22株志贺氏菌进行血清分型、药物敏感试验和PFGE试验。结果22株志贺氏菌血清分型:B群19株,占总数86.5%;C群1株,占总数的4.5%;D群2株,占总数的9.0%。成功建立了菌痢的PFGE分子分型方法,并将我省22株流行株分为若干带型。试验结果进一步作聚类分析。结论安徽省菌痢流行株以福氏为主;安徽省PFGE分子分型方法和初步带型数据库对提高细菌检测水平有一定意义。 相似文献
104.
105.
106.
107.
108.
Objective To evaluate the accuracy of automated quantification of myocardial perfusion imaging (MPI) using a method based on a Western normal database for the detection of coronary artery disease (CAD) in a group of Chinese patients. Methods Seventy-two Chinese patients who underwent coronary angiography (CAG) and MPI within 3 months were recruited into this study. Eighty selected from 140 Chinese patients with low probability of CAD ( < 5% ) were enrolled into local normal database of 99Tcm-methoxyisobutylisonitrile (MIBI) MPI using Cedars quantitative perfusion SPECT (QPS) database. Two Western MPI normal databases (CSMC MibiMbiAuto and Mibimibi) were used for processing the Chinese CAD patients recruited in this study, and the results were compared with those using local normal database and visual interpretation. T-test and z-test were used for statistical analysis. Results The extent (EXT)measurement obtained from Mibimibi and local database was ( 10.73 ± 14.54)% and ( 14.22 ± 16.51 )%,respectively ( t = 7.87, P < 0.001 ); the severity (SEV) was 1.07 ± 0.93 and 1.34 ± 1.20, respectively ( t =7.45, P<0.001). The area under curve(AUC) by using EXT measurement for local database (0.85 ±0.05) was larger than that for CSMC MibiMbiAuto ( AUC = 0.72 ± 0.06, z = 2.50, P < 0.01 ) and Mibimibi ( AUC = 0.77 ± 0.06, z = 2.47, P = 0.014). The AUC of local database showed no significant difference from that of visual interpretation (AUC=0.83 ±0.05, z=0.05, P>0.05). Conclusion Quantification of MPI of our Chinese patients using Western normal database would decrease the accuracy for the detection of CAD. 相似文献
109.
110.
目的探讨VEGFR-2、VEGF和MVD在肾上腺皮质癌(ACC)中的表达及其临床意义。方法选取经手术治疗且具有完整的临床、病理资料的肾上腺皮质肿瘤存档石蜡标本37例,其中良性组20例,恶性组(ACC组)17例。采用免疫组化技术,检测良、恶性肾上腺皮质肿瘤中VEGFR-2、VEGF和MVD的表达情况。结果 VEGFR-2在ACC组中呈高表达(76.47%),在良性组中表达较低(25.00%),ACC组与良性组之间VEGFR-2的表达有显著性差异(P0.05)。VEGF在ACC组中呈高表达(70.59%),在良性组中表达较低(25.00%),VEGF在ACC组中的表达与在良性组中的表达有显著性差异(P0.05)。MVD在ACC组中的表达为(76.40±15.64),良性组中为(21.05±8.07),两者之间有显著性差异(P0.05)。结论 VEGFR-2和VEGF以及MVD在ACC中的高表达为抗肿瘤血管生成治疗在ACC中的应用,提供了一定的理论依据。 相似文献